This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
The inspection was conducted from July 22-25, 2025
This collaboration aims to bridge India’s talent and translational gap in this rapidly growing field by equipping professionals with practical expertise in the manufacturing of advanced therapies.
This achievement underscores our unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance
ISG acknowledged Indegene's strengths in implementing holistic creative workflows, interoperability via robust integration with tech ecosystems
Changhua site meets international regulatory standards for global medical applications
This strategic move positions Sudeep Pharma to seamlessly integrate high-end premix capabilities with its mineral portfolio
For FY25, Revenue from operation grew 28.8 per cent YoY to Rs. 70.1 crore
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
This marks yet another milestone in our series of successful audits over the past year
Subscribe To Our Newsletter & Stay Updated
